Skip to content
healthcare.dev
Get a free key

FLUAD

NDC 70461-026, INFLUENZA A VIRUS A/Missouri/11/2025 IVR-279 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Michigan/105/2025 IVR-285 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/Tokyo/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED), injection, suspension, from Seqirus, Inc..

Product NDC
70461-026
Status
Listed
Labeler
Seqirus, Inc.
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA125510
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70461-026 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INFLUENZA A VIRUS A/MISSOURI/11/2025 IVR-279 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)15 ug/.5mL
  • INFLUENZA A VIRUS A/MICHIGAN/105/2025 IVR-285 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)15 ug/.5mL
  • INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED)15 ug/.5mL
Package NDCNDC-11Package
70461-026-037046100260310 SYRINGE, GLASS in 1 CARTON (70461-026-03) / .5 mL in 1 SYRINGE, GLASS (70461-026-04)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 70461-026 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70461-026 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70461-026. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.